1. Home
  2. SPOK vs SLP Comparison

SPOK vs SLP Comparison

Compare SPOK & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

HOLD

Current Price

$11.78

Market Cap

267.8M

ML Signal

HOLD

Logo Simulations Plus Inc.

SLP

Simulations Plus Inc.

HOLD

Current Price

$12.44

Market Cap

248.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPOK
SLP
Founded
2004
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
EDP Services
Sector
Telecommunications
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
267.8M
248.8M
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
SPOK
SLP
Price
$11.78
$12.44
Analyst Decision
Hold
Buy
Analyst Count
1
6
Target Price
$14.00
$25.00
AVG Volume (30 Days)
189.9K
253.8K
Earning Date
01-01-0001
04-07-2026
Dividend Yield
10.43%
N/A
EPS Growth
2.74
N/A
EPS
0.75
0.03
Revenue
$139,708,000.00
$59,577,000.00
Revenue This Year
$1.70
$2.64
Revenue Next Year
N/A
$6.01
P/E Ratio
$15.97
$411.00
Revenue Growth
1.49
10.52
52 Week Low
$11.68
$11.16
52 Week High
$19.31
$36.43

Technical Indicators

Market Signals
Indicator
SPOK
SLP
Relative Strength Index (RSI) 29.89 40.17
Support Level $11.68 $12.45
Resistance Level $13.72 $13.84
Average True Range (ATR) 0.43 0.51
MACD -0.09 0.29
Stochastic Oscillator 2.61 83.27

Price Performance

Historical Comparison
SPOK
SLP

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Share on Social Networks: